Corvidia Therapeutics Closes $60 Million Series B Round Led by Venrock

Edward Kim | |

Using precision genomics to develop cardiovascular and cardio-renal therapies.

​Immunovaccine’s DepoVax™ Continues to Play a Pivotal Role in the Future of Modern Medicine

Spotlight Companies | |

With its innovative DepoVax™ platform, Immunovaccine is quickly emerging as a leading name in the immunotherapy and cancer vaccine space of the life sciences sector.

​Eli Lilly: Solid as a Rock

MoneyShow | |

This is truly a worldwide leader in big pharma.

​How Eli Lilly’s $1.8 Billion Bet on Cancer Vaccines Puts Spotlight on Immunovaccine’s Anticipated Clinical Data

Spotlight Companies | |

Immunotherapeutics represent the potential for more precise cancer treatments than traditional oncology methods by harnessing the body’s own immune system.

Lilly Gets FDA Approval for Advanced Breast Cancer Treatment

Edward Kim | |

New targeted treatment option for certain patients with breast cancer who are not responding to existing therapies (Image: National Cancer Institute).

​Here's What The Latest Collaboration Deal Means For Eli Lilly and Co (NYSE:LLY) ­

Mark Collins | |

Here's a look at the recent announcement from Eli Lilly that it intends to team up with the Evotec spinout, Topas.

​Nektar Therapeutics: “A Slew of Good News”

MoneyShow | |

Nektar Therapeutics (NKTR) reported positive top-line data for its drug treatment under development in the opioid sector.

Adamis (ADMP): What's in the Pipeline After Generic EpiPen Approval?

Edward Kim | |

Adamis Pharmaceuticals is developing therapies for respiratory diseases and allergies.

Applied Genetic Technologies (AGTC): Gene Therapy for Opthalmology

Edward Kim | |

AGTC is developing treatments for severe opthalmological diseases using gene therapy.

IPO Report: Pfenex (PFNX)

Francis Gaskins | |

Pfenex ($PFNX) was a December 2009 spinout from The Dow Chemical Company (DOW) headquartered in San Diego, CA, Eleven other companies are scheduled for the week of July 14, 2014. The full

Sponsored Financial Content

Market Movers